ALFA Filings
Every announcement, straight from the exchange
Every Viyash Scientific acquisition announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Viyash Scientific's subsidiary completed the acquisition of BioForLife Italia s.r.l. for a total consideration of Rs.193.41 Crore. This transaction was previously announced in June.
Viyash Scientific's subsidiary completed the acquisition of Italy-based BioForLife Italia S.r.l. for a total consideration of approximately EUR 16.98 million.
Viyash Scientific Limited received Italian regulatory approval for its proposed 100% acquisition of BioForLife Italia S.r.l., with the completion timeline now extended by two months.
Viyash Scientific acquired 100% of Italy's BioForLife for ₹188 Crore. The strategic move strengthens its European companion animal health presence and global growth footprint.
Viyash Scientific acquired 100% of BioForLife Italia for €16.975 million (₹185.03 Crore). The acquisition strengthens the company's companion animal health presence in the Italian market.